However, there is still a concern regarding the increased risk of infections caused by the therapeutic inhibition of FcRn to remove the pathogenic and nonpathogenic IgG across the epithelial cells lining the respiratory tract (14, 15). This evidence concerns the gene FCGRT and infection.